WEAK BUY
The "go-to" position in the gold market. Extremely low cost producer. Very little political risk as they are focused in Canada. Very well run. Unhedged. Would wait for some upside, $4 or $5, in the gold sector before buying more.
WEAK BUY
Do have a weighting in some mertal producers, but not this one. If you believe the natural resource story continues, the metal stocks are probably inexpensive. In the last few months there has been a catchup in the oils and this hasn't happened as yet. Will likely be some strength in these companies, but would prefer the mid-size companies. In the large caps, prefers Teck Cominco (TEK.MV.A-T).
DON'T BUY
Share price is peforming very poorly in quite a strong market. There are concerns on the price of MBTE.
HOLD
Clearly there is an increase in the volatility in the energy stocks which happens when the market gets more extended. You have to know if you can stomach the volatility which is why they have scaled back their exposure. It is also the point where you can make the most money.
BUY
Manufacturer of memory, cards for computers, USB drives, cameras, etc. Price is not dropping as quickly as people expected. Coming into the Christmas season is a strong period.
HOLD
Not sure that now is the time to be entering new positions in the energy sector. Would be looking for these energy stocks to start to hit new highs again before considering adding new positions.
DON'T BUY
When you get bad news in the market, it can generally stay for some time. Shareholders that got in at higher prices are looking for their price in order to exit.
DON'T BUY
Pharmaceuticals is a group that has underperformed for about 3 years. This one, in relation to the rest of the group, has peformed better althoough all of them are retracing over the last couple of months. Prefers the bioceutical companies.
BUY
Fertilizer stocks have been the one shining light in the chemicals. Global demand for fertilizers is very strong. We are in a long cycle for the demand for fertilizers.
BUY
One of the strong companies in the metal sector. There is a potential over the next several months for a follow up bid for the rest of the company. The stock is just consolidating after a very strong run.
DON'T BUY
The medical device group is performing fairly well. The problem this company is having is that it is really a one product company which is a risk. Competition Johnson and Johnson (JNJ-N) has a product which is perceived to be safer so market share has dropped.
HOLD
A very attractive asset. Wouldn't be surprised to see the price driven up by another bid.
PAST TOP PICK
(A Top Pick May 3/05.) Picked this when his risk model went negative. A change came through in the beginning of June and entered the market again.
PAST TOP PICK
(A Top Pick May 3/05. Up 19%.) Still likes.
PAST TOP PICK
(A Top Pick May 3/05. Up 10%.) This company is winning in a sector that's having a tough time. Still likes.